Literature DB >> 4152327

The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy.

P M Shah, A G Adelman, E D Wigle, F L Gobel, H B Burchell, T Hardarson, R Curiel, C De La Calzada, C M Oakley, J F Goodwin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4152327

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  12 in total

Review 1.  Hypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment.

Authors:  C van der Lee; M J Kofflard; M L Geleijnse; F J Ten Cate
Journal:  Neth Heart J       Date:  2005-12       Impact factor: 2.380

2.  Hypertrophic cardiomyopathy, ten years' experience.

Authors:  J Kenny; C McCarthy; S Blake; P McCann; T B Counihan
Journal:  Ir J Med Sci       Date:  1987-02       Impact factor: 1.568

3.  Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy.

Authors:  P M Elliott; J R Gimeno; R Thaman; J Shah; D Ward; S Dickie; M T Tome Esteban; W J McKenna
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

4.  Natural history of hypertrophic cardiomyopathy.

Authors:  P M Elliott
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 2.931

Review 5.  The role of pharmacologic treatment to prevent sudden death in the implantable cardioverter defibrillator era.

Authors:  P M Elliott
Journal:  Curr Cardiol Rep       Date:  2001-03       Impact factor: 2.931

6.  Percutaneous transluminal septal reduction for hypertrophic obstructive cardiomyopathy: report from an international pilot study.

Authors:  Hope E Buell; Rodney H Stables; Elizabeth R DeLong; Kathy B Shuping; Donna M Killip; Harry M Lever; William J McKenna; David Rubin; Ulrich Sigwart; Morimasa Takayama; Galen S Wagner; Eric L Eisenstein; William H Spencer
Journal:  J Med Syst       Date:  2002-08       Impact factor: 4.460

7.  Left ventricular chamber dilatation in hypertrophic cardiomyopathy: related variables and prognosis in patients with medical and surgical therapy.

Authors:  C Seiler; R Jenni; G Vassalli; M Turina; O M Hess
Journal:  Br Heart J       Date:  1995-11

8.  Women with hypertrophic cardiomyopathy have worse survival.

Authors:  Jeffrey B Geske; Kevin C Ong; Konstantinos C Siontis; Virginia B Hebl; Michael J Ackerman; David O Hodge; Virginia M Miller; Rick A Nishimura; Jae K Oh; Hartzell V Schaff; Bernard J Gersh; Steve R Ommen
Journal:  Eur Heart J       Date:  2017-12-07       Impact factor: 29.983

9.  Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand.

Authors:  Nattakorn Songsirisuk; Veraprapas Kittipibul; Nilubon Methachittiphan; Vorawan Charoenattasil; Nath Zungsontiporn; Ittikorn Spanuchart; Saranya Buppajarntham; Charoen Mankongpaisarnrung; Sudarat Satitthummanid; Suphot Srimahachota; Pairoj Chattranukulchai; Smonporn Boonyaratavej Songmuang; Sarinya Puwanant
Journal:  BMC Cardiovasc Disord       Date:  2019-01-03       Impact factor: 2.298

Review 10.  Interrelationship Between Kidney Function and Percutaneous Mitral Valve Interventions: A Comprehensive Review.

Authors:  Kevin Bryan Lo; Sandeep Dayanand; Pradhum Ram; Pradeep Dayanand; Leandro N Slipczuk; Vincent M Figueredo; Janani Rangaswami
Journal:  Curr Cardiol Rev       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.